Biomarkers of acute kidney injury: a concise review of current literature

Abstract

Acute kidney injury (AKI), a medical condition associated with increased hospitalization rates which requires interdisciplinary management, is a major health concern because of the burden it places on the health systems of different countries. Biomarkers represent the focus of recent years in furthering the early diagnosis of AKI, providing new opportunities for correct prophylaxis or early therapeutic intervention so that the evolution of patients with this pathology is favorable and the risk of life-threatening complications is negligible.

Keywords

• acute kidney injury (aki)
• biomarkers
• cystatin c (cys-c)
• liver-type fatty acid-binding protein (l-fabp)
• neutrophil gelatinase-associated lipocalin (ngal)